Erratum to "Oral administration of Yokukansan inhibits the development of atopic dermatitis-like lesions in isolated NC/Nga mice" [J. Dermatol. Sci. 56 (2009) 37-42] (DOI:10.1016/j.jdermsci.2009.07.003);Oral administration of Yokukansan inhibits the development of atopic dermatitis-like lesions in isolated NC/Nga mice

Journal of Dermatological Science

Volumn 56, Issue 1, 2009, Pages 37-42

  Jiang, Ju ^a,d   Yamaguchi, Takuji ^a,c   Funakushi, Naoko ^a   Kuhara, Takatoshi ^a   Fan, Ping shen ^a   Ueki, Rie ^b   Suto, Hajime ^a   Kase, Yoshio ^c   Ikeda, Shigaku ^a   Ogawa, Hideoki ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO TOKYO KOTO GERIATRIC MEDICAL CENTER   (Japan)

^c TSUMURA AND CO   (Japan)

^d Fuzhou Dermatosis Prevention and Control Hospital   (China)

Author keywords

Anti itching; Atopic dermatitis; NC Nga mice; Social isolation; Stress; Yokukansan

Indexed keywords

ANTIDERMATOPHYTIC AGENT; CORTICOSTERONE; HERBACEOUS AGENT; IMMUNOGLOBULIN E; NERVE GROWTH FACTOR; UNCLASSIFIED DRUG; YOKUKANSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CELL INFILTRATION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATORY CELL; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCRATCHING; SOCIAL STRESS;

EID: 69049089653     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(09)00328-4     Document Type: Erratum

References (33)

1. Hashiro M., and Okumura M. Anxiety, depression and psychosomatic symptoms in patients with atopic dermatitis: comparison with normal controls and among groups of different degrees of severity. J Dermatol Sci 14 (1997) 63-67
2. Kimyai-Asadi A., and Usman A. The role of psychological stress in skin disease. J Cutan Med Surg 5 (2001) 140-145
3. Seiffert K., Hilbert E., Schaechinger H., Zouboulis C.C., and Deter H.C. Psychophysiological reactivity under mental stress in atopic dermatitis. Dermatology 210 (2005) 286-293
4. Hashizume H., Horibe T., Ohshima A., Ito T., Yagi H., and Takigawa M. Anxiety accelerates T-helper 2-tilted immune responses in patients with atopic dermatitis. Br J Dermatol 152 (2005) 1161-1164
5. Chida Y., Steptoe A., Hirakawa N., Sudo N., and Kubo C. The effects of psychological intervention on atopic dermatitis. Int Arch Allergy Immunol 144 (2007) 1-9
6. Linnet J., and Jemec G.B. An assessment of anxiety and dermatology life quality in patients with atopic dermatitis. Br J Dermatol 140 (1999) 268-272
7. Koblenzer C.S. Itching and the atopic skin. J Allergy Clin Immunol 104 (1999) S109-S113
8. Jiang J., Kuhara T., Ueki R., Zheng Y., Suto H., Ikeda S., et al. Inhibitory effects of paroxetine on the development of atopic dermatitis-like lesions in NC/Nga mice. J Dermatol Sci 47 (2007) 244-247
9. Terasawa K. KAMPO Japanese-Oriental Medicine: Insights from Clinical Cases (1993), Standard McIntyre, Tokyo
10. Koshikawa N., Imai T., Takahashi I., Yamauchi M., Sawada S., and Kansaku K. Effects of Hochu-eki-to, Yoku-kan-san and Saiko-ka-ryukotsu-borei-to on behavioral despair and acetic acid-induced writhing in mice. Methods Find Exp Clin Pharmacol 20 (1998) 47-51
11. Tahara E., Wu W.J.1, Satoh T., Yamada T., Kurosaki Nagai H., Nunome S., et al. Psychosocial stress enhances IgE-mediated triphasic cutaneous reaction in mice: antagonism by Yokukan-san (a Kampo medicine) and diazepam. Allergol Int 50 (2001) 211-222
12. Matsuda H., Watanabe N., Geba G.P., Sperl J., Tsudzuki M., Hiroi J., et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 9 (1997) 461-466
13. Suto H., Matsuda H., Mitsuishi K., Hira K., Uchida T., Unno T., et al. NC/Nga mice: a mouse model for atopic dermatitis. Int Arch Allergy Immunol 120 (1999) 70-75
14. Yamaguchi T., Maekawa T., Nishikawa Y., Nojima H., Kaneko M., Kawakita T., et al. Characterization of itch-associated responses of NC mice with mite-induced chronic dermatitis. J Dermatol Sci 25 (2001) 20-28
15. Kim J.W., and Kirkpatrick B. Social isolation in animal models of relevance to neuropsychiatric disorders. Biol Psychiatry 40 (1996) 918-922
16. Bowers S.L., Bilbo S.D., Dhabhar F.S., and Nelson R.J. Stressor-specific alterations in corticosterone and immune responses in mice. Brain Behav Immun 22 (2008) 105-113
17. Ojima K., Matsumoto K., Tohda M., and Watanabe H. Hyperactivity of central noradrenergic and CRF systems is involved in social isolation-induced decrease in pentobarbital sleep. Brain Res 684 (1995) 87-94
18. Pashko S., Deyurck K.H., and Vogel W.H. Use of the catheterized rat in studies on social interaction and plasma catecholamine. Pharmacol Biochem Behav 13 (1980) 471-473
19. Nguyen T.T., Matsumoto K., Yamasaki K., and Watanabe H. Majonoside-R2 reverses social isolation stress-induced decrease in pentobarbital sleep in mice: Possible involvement of neuroactive steroids. Life Sci 61 (1997) 395-402
20. Welch J.M., Lu J., Rodriguiz R.M., Trotta N.C., Peca J., Ding J.D., et al. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature 23 (2007) 894-900
21. Kondo K., Nagami T., and Teramoto S. Differences in haematopoietic death among inbred strains of mice. In: Bond S.V., and Sugahara T. (Eds). Comparative cellular and species radiosensitivity (1964), Igakushoin, Tokyo 20-29
22. Ständer S., Steinhoff M., Schmelz M., Weisshaar E., Metze D., and Luger T. Neurophysiology of pruritus: cutaneous elicitation of itch. Arch Dermatol 139 (2003) 1463-1470
23. Elenkov I.J. Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochem Int 52 (2008) 40-51
24. Paus R., Schmelz M., Bíró T., and Steinhoff M. Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest 116 (2006) 1174-1186
25. Arck P., and Paus R. From the brain-skin connection: the neuroendocrine-immune misalliance of stress and itch. Neuroimmunomodulation 13 (2006) 347-356
26. Amano H., Negishi I., Akiyama H., and Ishikawa O. Psychological stress can trigger atopic dermatitis in NC/Nga mice: an inhibitory effect of corticotropin-releasing factor. Neuropsychopharmacology 33 (2008) 566-573
27. Singh L.K., Boucher W., Pang X., Letourneau R., Seretakis D., Green M., et al. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors. J Pharmacol Exp Ther 288 (1999) 1349-1356
28. Slominski A., Wortsman J., Luger T., Paus R., and Solomon S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 80 (2000) 979-1020
29. Theoharides T.C., Singh L.K., Boucher W., Pang X., Letourneau R., Webster E., et al. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 139 (1998) 403-413
30. Cassano Jr. W.J., and D'mello A.P. Acute stress-induced facilitation of the hypothalamic-pituitary-adrenal axis: evidence for the roles of stressor duration and serotonin. Neuroendocrinology 74 (2001) 167-177
31. Miyata K., Ito H., and Fukudo S. Involvement of the 5-HT3 receptor in CRH-induce defecation in rats. Am J Physiol 274 (1998) 827-831
32. Tateno M., Ukai W., Ono T., Saito S., Hashimoto E., and Saito T. Neuroprotective effects of Yi-Gan San against beta amyloid-induced cytotoxicity on rat cortical neurons. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008) 1704-1707
33. Egashira N., Iwasaki K., Ishibashi A., Hayakawa K., Okuno R., Abe M., et al. Repeated administration of Yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT)2A receptors in the prefrontal cortex. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008) 1516-1520